Excessive PRL secretion leads to hypogonadism in both sexes, with the type and severity of clinical symptoms depending on the sex, PRL levels, disease duration, tumor size, and the extent of hyperprolactinemia [1,2,3,4,5,6]. This evidence concerns the gene PRL and neoplasm.